To confirm this, we established cisplatin resistant ovarian cancer cell line using TOV-21G cells, which have low FOXM1 expression than SKOV-3 cell (Figure S3) and performed an immunoblotting assay in TOV-21G and cisplatin-resistant TOV-21G cells. This evidence concerns the gene FOXM1 and ovarian carcinoma.